Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 4/Signature 1

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/11/09

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 4: Figure S4

Description: Differentially abundant bacterial taxa between the naive and TB + HRZ groups at 3months into anti-tuberculosis HR(H-Isoniazid, R-Rifampin) therapy.

Abundance in Group 1: increased abundance in TB +HRZ group - 3months HR(W16)

NCBI	Quality Control	Links
Barnesiella
Tannerella
Porphyromonas
Odoribacter
Prolixibacter
Anaerorhabdus
Parabacteroides
Paraprevotella
Parasutterella
Paraeggerthella
Brenneria
Bifidobacterium
Desulfovibrio
Parvibacter
Adlercreutzia
Marvinbryantia
Eggerthia
Enterococcus
Olsenella

Revision editor(s): KateRasheed